Hypoxia-inducible factor-1: a novel therapeutic target for the management of cancer, drug resistance, and cancer-related pain

BP Bui, PL Nguyen, K Lee, J Cho - Cancers, 2022 - mdpi.com
Simple Summary Accumulating evidence indicates that hypoxia-inducible factor-1 (HIF-1)
plays a pivotal role in tumor biology, particularly in hypoxic environments. Over the past few …

Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer

P Bharathiraja, P Yadav, A Sajid, SV Ambudkar… - Drug Resistance …, 2023 - Elsevier
ATP-binding cassette (ABC) transporters such as ABCB1, ABCG2, and ABCC1 are the
major players in drug efflux-mediated multidrug resistance (MDR), which severely affects the …

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

JM Gajer, SD Furdas, A Gründer, M Gothwal… - Oncogenesis, 2015 - nature.com
We have previously described novel histone acetyltransferase (HAT) inhibitors that block
neuroblastoma cell growth in vitro. Here we show that two selected pyridoisothiazolone HAT …

New evidence for P-gp-mediated export of amyloid-β peptides in molecular, blood-brain barrier and neuronal models

AB Chai, AMS Hartz, X Gao, A Yang… - International journal of …, 2020 - mdpi.com
Defective clearance mechanisms lead to the accumulation of amyloid-beta (Aβ) peptides in
the Alzheimer's brain. Though predominantly generated in neurons, little is known about …

Synthesis, characterization and anti-cancer activity of hydrazide derivatives incorporating a quinoline moiety

M Bingul, O Tan, CR Gardner, SK Sutton, GM Arndt… - Molecules, 2016 - mdpi.com
Identification of the novel (E)-N′-((2-chloro-7-methoxyquinolin-3-yl) methylene)-3-
(phenylthio) propanehydrazide scaffold 18 has led to the development of a new series of …

Epigenetic regulation of multidrug resistance protein 1 and breast cancer resistance protein transporters by histone deacetylase inhibition

D You, JR Richardson, LM Aleksunes - Drug Metabolism and Disposition, 2020 - ASPET
Multidrug resistance protein 1 (MDR1, ABCB1, P-glycoprotein) and breast cancer resistance
protein (BCRP, ABCG2) are key efflux transporters that mediate the extrusion of drugs and …

Dual kinase inhibition of EGFR/HER2: design, synthesis and molecular docking of thiazolylpyrazolyl‐based aminoquinoline derivatives as anticancer agents

RZ Batran, WA El‐Kashak, SM El‐Daly… - …, 2021 - Wiley Online Library
Two new series of aminoquinoline based derivatives (thiazolyl pyrazolines and pyrazolyl
thiazolidinones) were designed and synthesized. The in vitro antiporliferative activity of the …

[HTML][HTML] Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo

Y Zhao, D Yu, H Wu, H Liu, H Zhou… - International …, 2014 - spandidos-publications.com
Suberoylanilide hydroxamic acid (SAHA), a potent pan-histone deacetylase (HDAC)
inhibitor, has been clinically approved for the treatment of cutaneous T-cell lymphoma …

Synthesis of dihydrazones as potential anticancer and dna binding candidates: a validation by molecular docking studies

MB Sridhara, KP Rakesh… - Anti-Cancer Agents …, 2020 - ingentaconnect.com
Background: Accounting for mortality nearly one in four of human and second highest
leading cause of death worldwide. Every year, about 10 million new cancers are diagnosed …

Mesenchymal change and drug resistance in neuroblastoma

JA Naiditch, C Jie, TB Lautz, S Yu, S Clark… - Journal of Surgical …, 2015 - Elsevier
Background Metastatic initiation has many phenotypic similarities to epithelial-to-
mesenchymal transition, including loss of cell–cell adhesion, increased invasiveness, and …